Clinical Trials Logo

AAT Deficiency clinical trials

View clinical trials related to AAT Deficiency.

Filter by:
  • None
  • Page 1

NCT ID: NCT01851642 Recruiting - Clinical trials for Alpha-1 Antitrypsin Deficiency

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

Start date: September 2007
Phase: N/A
Study type: Observational

The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their ability to work.

NCT ID: NCT01810458 Active, not recruiting - Liver Fibrosis Clinical Trials

Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (AATD)

Start date: October 2013
Phase: N/A
Study type: Observational

We hypothesize that individuals with Alpha-1 Antitrypsin (AAT) deficiency have ongoing liver injury which is not detected by the usual blood tests used to look at liver function. This ongoing liver injury leads to cirrhosis in a significant number of adults with AAT deficiency.